- Home
- PODD vs TEVA Comparison
PODD vs TEVA Comparison
Compare PODD & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- TEVA
- Stock Information
- Founded
- PODD 2000
- TEVA 1901
- Country
- PODD United States
- TEVA Israel
- Employees
- PODD N/A
- TEVA N/A
- Industry
- PODD Medical/Dental Instruments
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- PODD Health Care
- TEVA Health Care
- Exchange
- PODD Nasdaq
- TEVA Nasdaq
- Market Cap
- PODD 21.5B
- TEVA 21.2B
- IPO Year
- PODD 2007
- TEVA N/A
- Fundamental
- Price
- PODD $331.83
- TEVA $18.15
- Analyst Decision
- PODD Strong Buy
- TEVA Strong Buy
- Analyst Count
- PODD 18
- TEVA 7
- Target Price
- PODD $332.22
- TEVA $24.71
- AVG Volume (30 Days)
- PODD 697.4K
- TEVA 12.8M
- Earning Date
- PODD 08-07-2025
- TEVA 07-30-2025
- Dividend Yield
- PODD N/A
- TEVA N/A
- EPS Growth
- PODD N/A
- TEVA N/A
- EPS
- PODD 3.32
- TEVA N/A
- Revenue
- PODD $2,359,500,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- PODD $24.54
- TEVA $5.19
- Revenue Next Year
- PODD $17.48
- TEVA $0.16
- P/E Ratio
- PODD $99.86
- TEVA N/A
- Revenue Growth
- PODD 26.00
- TEVA 2.08
- 52 Week Low
- PODD $180.31
- TEVA $12.47
- 52 Week High
- PODD $334.18
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- PODD 68.39
- TEVA 61.76
- Support Level
- PODD $327.17
- TEVA $17.33
- Resistance Level
- PODD $334.18
- TEVA $19.10
- Average True Range (ATR)
- PODD 8.48
- TEVA 0.48
- MACD
- PODD 2.55
- TEVA 0.16
- Stochastic Oscillator
- PODD 95.05
- TEVA 68.85
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.